Nosopharm Information

Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus.

Website	http://www.nosopharm.com
Revenue	$811000
Employees	1 (1 on RocketReach)
Founded	2009
Address	21 Ave Georges Pompidou, Lyon, Auvergne-Rhone-Alpes 69486, FR
Phone	+33 4 66 26 53 21
Technologies	JavaScript , HTML , PHP +11 more (view full list)
Industry	Biotechnology, Business Services General, Business Services, Science and Engineering, Pharmaceutical, Health Care, Product Research, Data and Analytics, Design
Web Rank	28 Million
Keywords	Innovation, Antimicrobial Resistance, Biopharma, Antibiotic Resistance, Drug Discovery, Pharmaceutical Research, Biotechnology, Infection Treatment, Drug Development, Antibacterial Agents, Clinical Trials, Pharmaceutical, Therapeutics, Microbiology, Medicine, Health, Research, Science
Competitors	Debiopharm, CureVac, Paratek Pharmaceuticals, Theravance Biopharma US, Inc., Caribou Biosciences, Optima Pharmaceuticals Inc, SCYNEXIS, Inc., Nabriva Therapeutics plc, Entasis Therapeutics, Athera Biotechnologies AB +39 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies